DIA/Tufts CSDD Research: AI Saving Time in Drug Development
DIA and the Tufts Center for the Study of Drug Development (Tufts CSDD), in collaboration with 16 biopharmaceutical companies and CROs, cond...
Radio and PodcastLive Radio & PodcastsScience & Medicine
DIA: Driving Insights to Action
DIA is a global, multidisciplinary, membership association of healthcare professionals that works towards the advancement of lifesaving medicines, therapies, and technologies around the worl...
Episodes
20 episodesDIA: Your Partner in Life Sciences Training and Development
This podcast by the Drug Information Association (DIA) highlights the significant benefits of investing in professional development programs...
DIA: Going Beyond the Traditional Definition of Drug Development
In this DIA 60th anniversary interview, former Board President Ling Su shares his thoughts on the two most important aspects of DIA’s future...
GPP Experts Explain Authorship Algorithm
Good Publication Practice (GPP) experts explain the authorship algorithm designed to weigh each author's contribution relative to other auth...
"Dossier in the Cloud" Democratizing Global Access
Accumulus Synergy CEO Francisco Nogueira shares expectations for the outcomes of a post-approval changes pilot led by Roche which utilizes t...
DIA: A Place Where You Can Make a Difference
Listen to former DIA Board President Minnie Baylor-Henry’s special message to DIA members as part of DIA’s 60th Anniversary celebration in 2...
Autumn’s Leukemia Story: Regimens, Recovery, and Realizations
A few years ago, 8-year-old Autumn noticed a lump on the side of her neck as she was preparing for bed one night. That quiet night opened a...
Retiring TGA Head Maps Australia’s Post-Pandemic Future
In April 2023, Professor John Skerritt retired after 11 years of exemplary public service as deputy secretary of the Health Products Regulat...
Patient Engagement: Evolution of Who Knows What, Part 2
In part two of this podcast, “ePatients” Dave deBronkart and Stacy Hurt (Patient Advocacy Ambassador, Parexel) discuss new opportunities in...
Patient Engagement: Evolution of Who Knows What, Part 1
DIA GAM 2023 Patient Engagement track chair Pujita Vaidya discusses the definition, history, and current state of patient engagement in clin...
Australian Clinical Trials Alliance Part 2 – Future Projections
“Healthcare systems obviously have as their primary role the delivery of healthcare,” says Steve Webb, Australian Clinical Trials Alliance b...
ANVISA Explains Innovative Online Optimized Assessment Project
For regulators in Brazil, the pandemic’s aftermath includes a backlog of post-approval changes, delayed by emergency development of COVID-19...
Australian Clinical Trials Alliance Part 1 – Current Perceptions
“The pandemic had a substantial impact on community understanding of clinical trials. Having said that, the sort of ambient level of communi...
Looking Back and Ahead: Translational Science Advances Impacting Patient Care
From microphysiological systems and digital pathology to next-generation-sequencing and diversity in foundational genomic data sets: In this...
Rwanda Welcomes African Medicines Agency Home
While the African Medicines Agency (AMA) plans and plants its inaugural headquarters in Rwanda, the European Commission, the European Medici...
Will Technology Solve the Research “People Problem”?
Clinical trials struggle to enroll eligible patients, while interested patients have difficulty finding pertinent clinical trials. Can techn...
Why Trans/Nonbinary Research Benefits All Communities
Actions to increase patient diversity in clinical research initially addressed racial and ethnic demographics but are expanding to address g...
Digital Revolutionizing Data-Driven Reimbursement
Digital technologies are rippling through clinical research and care, promising deeper links between healthcare research and delivery. In he...
China Sets New Record for Local Drug Approvals in 2021
DIA Global Forum ’s annual review of new drug approvals in China has shown growth in both the number and types of new drugs approved in Chin...
WHO Pilot Formalizes CSA Process to Assist Developers
The World Health Organization has initiated a pilot coordinated scientific advice (CSA) procedure whereby product developers may obtain WHO...